Cargando…

Identification of AK4 as a novel therapeutic target for serous ovarian cancer

The present study aimed to assess the expression level of adenylate kinase 4 (AK4) in human serous ovarian cancer (SOC) tissues and investigate the possible involvement of AK4 in SOC progression. Bioinformatics analysis based on The Cancer Genome Atlas (TCGA) database and immunohistochemical (IHC) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Minmin, Qin, Xinlei, Wang, Yuwei, Mao, Furong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583734/ https://www.ncbi.nlm.nih.gov/pubmed/33123257 http://dx.doi.org/10.3892/ol.2020.12209

Ejemplares similares

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer
por: Newtson, Andreea, et al.
Publicado: (2021)

Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
por: Moran-Jones, Kim, et al.
Publicado: (2015)

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
por: Stany, Michael P., et al.
Publicado: (2011)

Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer
por: Matthews, Bayley G., et al.
Publicado: (2021)

Identification of metastasis and prognosis-associated genes for serous ovarian cancer
por: Yang, Yijun, et al.
Publicado: (2020)

ak 47 /
por: Aguilar Martínez, Luis
Publicado: (2017)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer
por: Wada, Miku, et al.
Publicado: (2020)

Further Understanding of High-Grade Serous Ovarian Carcinogenesis: Potential Therapeutic Targets
por: Voutsadakis, Ioannis A
Publicado: (2020)

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022)

Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
por: He, Jiangnan, et al.
Publicado: (2021)

Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer
por: Zheng, Mingjun, et al.
Publicado: (2021)

KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer
por: De Donato, Marta, et al.
Publicado: (2020)

The Role of Mesothelin Expression in Serous Ovarian Carcinoma: Impacts on Diagnosis, Prognosis, and Therapeutic Targets
por: Giordano, Giovanna, et al.
Publicado: (2022)

TRPs in Ovarian Serous Cystadenocarcinoma: The Expression Patterns, Prognostic Roles, and Potential Therapeutic Targets
por: Zhang, Cheng, et al.
Publicado: (2022)

SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer
por: Wang, Huihuan, et al.
Publicado: (2021)

The association of ODF4 with AK1 and AK2 in mice is essential for fertility through its contribution to flagellar shape
por: Ito, Chizuru, et al.
Publicado: (2023)

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
por: Huang, He, et al.
Publicado: (2012)

A Novel ZIP4-HDAC4-VEGFA Axis in High-Grade Serous Ovarian Cancer
por: Fan, Qipeng, et al.
Publicado: (2021)

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
por: Chen, Steven F., et al.
Publicado: (2018)

NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach
por: Bekos, Christine, et al.
Publicado: (2019)

High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
por: Lisio, Michael-Antony, et al.
Publicado: (2019)

ZIP4 Is a Novel Cancer Stem Cell Marker in High-Grade Serous Ovarian Cancer
por: Fan, Qipeng, et al.
Publicado: (2020)

Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target
por: Fernandez, Marta Llaurado, et al.
Publicado: (2019)

The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma
por: Chesnokov, Mikhail S., et al.
Publicado: (2021)

The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma
por: Agarwal, Sumit, et al.
Publicado: (2013)

Notch signaling in serous ovarian cancer
por: Groeneweg, Jolijn W, et al.
Publicado: (2014)

The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer
por: Yan, Shunfei, et al.
Publicado: (2017)

Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma
por: Zhu, Yu-Ting, et al.
Publicado: (2023)

Non-stability of AK-invariant
por: Bandman, T, et al.
Publicado: (2003)

Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer
por: Leffers, N, et al.
Publicado: (2010)

Identification of Potential Prognostic Competing Triplets in High-Grade Serous Ovarian Cancer
por: Zhao, Jian, et al.
Publicado: (2021)

Identification of an Individualized Prognostic Biomarker for Serous Ovarian Cancer: A Qualitative Model
por: Luo, Fengyuan, et al.
Publicado: (2022)

Identification of clinical and molecular features of recurrent serous borderline ovarian tumour
por: Lu, Ziyang, et al.
Publicado: (2022)

Identification of the lncRNA, AK156230, as a novel regulator of cellular senescence in mouse embryonic fibroblasts
por: Chen, Yu-ning, et al.
Publicado: (2016)

Amplified therapeutic targets in high-grade serous ovarian carcinoma – a review of the literature with quantitative appraisal
por: Talbot, Thomas, et al.
Publicado: (2023)

The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
por: Brown, Patrick O., et al.
Publicado: (2009)

A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
por: Aide, Nicolas, et al.
Publicado: (2021)

Identification of candidate genes associated with tubal origin of high-grade serous ovarian cancer
por: Xiang, Li, et al.
Publicado: (2018)

Prediction of chemo-response in serous ovarian cancer
por: Gonzalez Bosquet, Jesus, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o6tpa5ebvrum1gcrh44v52ff6u